The purpose of this study was to bacterially express, purify, and refold combinations of the extracellular immunoglobulin (Ig)-like domains (2-3, 1-3, and 1-5) of the human -platelet-derived growth factor receptor (PDGFR) to characterize molecular interactions with its ligand, platelet-derived growth factor (PDGF). The far UV circular dichroism spectroscopy of the -PDGFR extracellular domains (ECDs) revealed a predominantly -sheet protein, with a structure consistent with folded Ig-like domains. The addition of PDGF-BB to these ECD types changed the conformation of all three types with a decrease in mean residue ellipticity in the following rank order: 1-5 = 1-3 > 2-3. In striking contrast, addition of PDGF-AA to these ECD types markedly changed the conformation of ECD 2-3, by an increased mean residue ellipticity but no changes were observed for ECDs 1-3 and 1-5. PDGF-AA bound to the immobilized ECD types 2-3, 1-3, and 1-5 at concentrations of 20, 11, and 7.5 nM, respectively. In contrast, PDGF-BB bound the ECD types 2-3, 1-3, and 1-5 at concentrations of 3, 3, and 2.2 nM, respectively. Scatchard analysis of binding studies using labeled ECDs indicated that PDGF-BB bound ECD 1-3 and ECD 2-3 with K values of 74 and 72 nM, respectively. While, PDGF-AA bound ECD 1-3 and ECD 2-3 with K values of 33 and 87 nM, respectively. Therefore, our results indicated that the loss of ECD 1 impaired the binding affinity of PDGFR ECD 1-3 toward PDGF-AA without having a similar effect on PDGF-BB binding. Together all of our data suggest that ECD 1 is differentially required for proper orientation of PDGF-AA but not PDGF-BB binding determinant within ECDs 2 and 3.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. Rolny, D. Spillmann, U. Lindahl, and L. Claesson-Welsh Heparin Amplifies Platelet-derived Growth Factor (PDGF)- BB-induced PDGF alpha -Receptor but Not PDGF beta -Receptor Tyrosine Phosphorylation in Heparan Sulfate-deficient Cells. EFFECTS ON SIGNAL TRANSDUCTION AND BIOLOGICAL RESPONSES J. Biol. Chem., May 24, 2002; 277(22): 19315 - 19321. [Abstract] [Full Text] [PDF]

				T. Mitsuda, K. Furukawa, S. Fukumoto, H. Miyazaki, T. Urano, and K. Furukawa Overexpression of Ganglioside GM1 Results in the Dispersion of Platelet-derived Growth Factor Receptor from Glycolipid-enriched Microdomains and in the Suppression of Cell Growth Signals J. Biol. Chem., March 22, 2002; 277(13): 11239 - 11246. [Abstract] [Full Text] [PDF]

				D. Lu, P. Kussie, B. Pytowski, K. Persaud, P. Bohlen, L. Witte, and Z. Zhu Identification of the Residues in the Extracellular Region of KDR Important for Interaction with Vascular Endothelial Growth Factor and Neutralizing Anti-KDR Antibodies J. Biol. Chem., May 5, 2000; 275(19): 14321 - 14330. [Abstract] [Full Text] [PDF]

				C.-H. Heldin and B. Westermark Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor Physiol Rev, October 1, 1999; 79(4): 1283 - 1316. [Abstract] [Full Text] [PDF]

				K. Miyazawa, G. Backstrom, O. Leppanen, C. Persson, C. Wernstedt, U. Hellman, C.-H. Heldin, and A. Ostman Role of Immunoglobulin-like Domains 2-4 of the Platelet-derived Growth Factor alpha -Receptor in Ligand-Receptor Complex Assembly J. Biol. Chem., September 25, 1998; 273(39): 25495 - 25502. [Abstract] [Full Text] [PDF]

				G. Fuh, B. Li, C. Crowley, B. Cunningham, and J. A. Wells Requirements for Binding and Signaling of the Kinase Domain Receptor for Vascular Endothelial Growth Factor J. Biol. Chem., May 1, 1998; 273(18): 11197 - 11204. [Abstract] [Full Text] [PDF]

				N. A. Lokker, J. P. O'Hare, A. Barsoumian, J. E. Tomlinson, V. Ramakrishnan, L. J. Fretto, and N. A. Giese Functional Importance of Platelet-derived Growth Factor (PDGF) Receptor Extracellular Immunoglobulin-like Domains. IDENTIFICATION OF PDGF BINDING SITE AND NEUTRALIZING MONOCLONAL ANTIBODIES J. Biol. Chem., December 26, 1997; 272(52): 33037 - 33044. [Abstract] [Full Text] [PDF]

				A. Uren, J. Jakus, J. F. de Mora, A. Yeudall, E. Santos, S. Gutkind, and M. A. Heidaran Carboxyl-terminal Domain of p27Kip1 Activates CDC2 J. Biol. Chem., August 29, 1997; 272(35): 21669 - 21672. [Abstract] [Full Text] [PDF]

				B. Barleon, F. Totzke, C. Herzog, S. Blanke, E. Kremmer, G. Siemeister, D. Marme, and G. Martiny-Baron Mapping of the Sites for Ligand Binding and Receptor Dimerization at the Extracellular Domain of the Vascular Endothelial Growth Factor Receptor FLT-1 J. Biol. Chem., April 18, 1997; 272(16): 10382 - 10388. [Abstract] [Full Text] [PDF]

				T. Hosoda, K. Monzen, Y. Hiroi, T. Oka, E. Takimoto, Y. Yazaki, R. Nagai, and I. Komuro A Novel Myocyte-specific Gene Midori Promotes the Differentiation of P19CL6 Cells into Cardiomyocytes J. Biol. Chem., September 14, 2001; 276(38): 35978 - 35989. [Abstract] [Full Text] [PDF]